TY - JOUR
T1 - Targeting mechanoresponsive proteins in pancreatic cancer
T2 - 4-hydroxyacetophenone blocks dissemination and invasion by activating MYH14
AU - Surcel, Alexandra
AU - Schiffhauer, Eric S.
AU - Thomas, Dustin G.
AU - Zhu, Qingfeng
AU - DiNapoli, Kathleen T.
AU - Herbig, Maik
AU - Otto, Oliver
AU - West-Foyle, Hoku
AU - Jacobi, Angela
AU - Krater, Martin
AU - Plak, Katarzyna
AU - Guck, Jochen
AU - Jaffee, Elizabeth M.
AU - Iglesias, Pablo A.
AU - Anders, Robert A.
AU - Robinson, Douglas N.
N1 - Publisher Copyright:
© 2019 American Association for Cancer Research.
PY - 2019/9/15
Y1 - 2019/9/15
N2 - Metastasis is complex, involving multiple genetic, epigenetic, biochemical, and physical changes in the cancer cell and its microenvironment. Cells with metastatic potential are often characterized by altered cellular contractility and deformability, lending them the flexibility to disseminate and navigate through different microenvironments. We demonstrate that mechanoresponsiveness is a hallmark of pancreatic cancer cells. Key mechanoresponsive proteins, those that accumulate in response to mechanical stress, specifically nonmuscle myosin IIA (MYH9) and IIC (MYH14), a-actinin 4, and filamin B, were highly expressed in pancreatic cancer as compared with healthy ductal epithelia. Their less responsive sister paralogs—myosin IIB (MYH10), a-actinin 1, and filamin A—had lower expression differential or disappeared with cancer progression. We demonstrate that proteins whose cellular contributions are often overlooked because of their low abundance can have profound impact on cell architecture, behavior, and mechanics. Here, the low abundant protein MYH14 promoted metastatic behavior and could be exploited with 4-hydroxyaceto-phenone (4-HAP), which increased MYH14 assembly, stiffening cells. As a result, 4-HAP decreased dissemination, induced cortical actin belts in spheroids, and slowed retrograde actin flow. 4-HAP also reduced liver metastases in human pancreatic cancer-bearing nude mice. Thus, increasing MYH14 assembly overwhelms the ability of cells to polarize and invade, suggesting targeting the mechanoresponsive proteins of the actin cytoskeleton as a new strategy to improve the survival of patients with pancreatic cancer. Significance: This study demonstrates that mechanoresponsive proteins become upregulated with pancreatic cancer progression and that this system of proteins can be pharma-cologically targeted to inhibit the metastatic potential of pancreatic cancer cells.
AB - Metastasis is complex, involving multiple genetic, epigenetic, biochemical, and physical changes in the cancer cell and its microenvironment. Cells with metastatic potential are often characterized by altered cellular contractility and deformability, lending them the flexibility to disseminate and navigate through different microenvironments. We demonstrate that mechanoresponsiveness is a hallmark of pancreatic cancer cells. Key mechanoresponsive proteins, those that accumulate in response to mechanical stress, specifically nonmuscle myosin IIA (MYH9) and IIC (MYH14), a-actinin 4, and filamin B, were highly expressed in pancreatic cancer as compared with healthy ductal epithelia. Their less responsive sister paralogs—myosin IIB (MYH10), a-actinin 1, and filamin A—had lower expression differential or disappeared with cancer progression. We demonstrate that proteins whose cellular contributions are often overlooked because of their low abundance can have profound impact on cell architecture, behavior, and mechanics. Here, the low abundant protein MYH14 promoted metastatic behavior and could be exploited with 4-hydroxyaceto-phenone (4-HAP), which increased MYH14 assembly, stiffening cells. As a result, 4-HAP decreased dissemination, induced cortical actin belts in spheroids, and slowed retrograde actin flow. 4-HAP also reduced liver metastases in human pancreatic cancer-bearing nude mice. Thus, increasing MYH14 assembly overwhelms the ability of cells to polarize and invade, suggesting targeting the mechanoresponsive proteins of the actin cytoskeleton as a new strategy to improve the survival of patients with pancreatic cancer. Significance: This study demonstrates that mechanoresponsive proteins become upregulated with pancreatic cancer progression and that this system of proteins can be pharma-cologically targeted to inhibit the metastatic potential of pancreatic cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=85072234499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072234499&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-18-3131
DO - 10.1158/0008-5472.CAN-18-3131
M3 - Article
C2 - 31358530
AN - SCOPUS:85072234499
SN - 0008-5472
VL - 79
SP - 4665
EP - 4678
JO - Cancer Research
JF - Cancer Research
IS - 18
ER -